Molecular weight (DA)
15kD
Immunogen
The antiserum was produced against synthesized peptide derived from human ORAV1. AA range:81-130
Specificity
ORAOV1 Polyclonal Antibody detects endogenous levels of ORAOV1 protein.
Formulation
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Dilution rate
Western Blot: 1/500 - 1/2000. Immunohistochemistry: 1/100 - 1/300. Immunofluorescence: 1/200 - 1/1000. ELISA: 1/10000. Not yet tested in other applications.
Purification process (Immunogen)
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Background
miscellaneous:Amplified and overexpressed in oral cancer cells.,similarity:Belongs to the ORAOV1 family.,tissue specificity:Widely expressed. Highly expressed in placenta, kidney and skeletal muscle.,
Function
miscellaneous:Amplified and overexpressed in oral cancer cells.,similarity:Belongs to the ORAOV1 family.,tissue specificity:Widely expressed. Highly expressed in placenta, kidney and skeletal muscle.,
Protein name
Oral cancer-overexpressed protein 1
Other name
ORAOV1; TAOS1; Oral cancer-overexpressed protein 1; Tumor-amplified and overexpressed sequence 1
Human protein sequence Database
Q8WV07
Mouse protein sequence database
Q8CH62
Rat protein sequence database
Cellular localization
Nucleus .
Tissue expression
Widely expressed. Highly expressed in placenta, kidney and skeletal muscle.